The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized study

BACKGROUND: The Global Programme to Eliminate Lymphatic Filariasis (GPELF) provides antifilarial medications to hundreds of millions of people annually to treat filarial infections and prevent elephantiasis. Recent trials have shown that a single-dose, triple-drug treatment (ivermectin with diethylc...

Descripción completa

Detalles Bibliográficos
Autores principales: Weil, Gary J., Bogus, Joshua, Christian, Michael, Dubray, Christine, Djuardi, Yenny, Fischer, Peter U., Goss, Charles W., Hardy, Myra, Jambulingam, Purushothaman, King, Christopher L., Kuttiat, Vijesh Sridhar, Krishnamoorthy, Kaliannagounder, Laman, Moses, Lemoine, Jean Frantz, O’Brian, Katiuscia K., Robinson, Leanne J., Samuela, Josaia, Schechtman, Kenneth B., Sircar, Anita, Srividya, Adinarayanan, Steer, Andrew C., Supali, Taniawati, Subramanian, Swaminathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590784/
https://www.ncbi.nlm.nih.gov/pubmed/31233507
http://dx.doi.org/10.1371/journal.pmed.1002839

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590784/
https://www.ncbi.nlm.nih.gov/pubmed/31233507
http://dx.doi.org/10.1371/journal.pmed.1002839

Ejemplares similares